To read this content please select one of the options below:

Connections between specific mental health diagnoses of schizophrenia, bipolar disorder and schizoaffective disorder and primary substance use

Gavin Foster (Dual Diagnosis and Service Development Department, Eastern Health, Box Hill, Australia)
David Taylor (Office of Research and Ethics, Eastern Health Institute, Eastern Health, Box Hill, Australia)
Stephanie Gough (Dual Diagnosis and Service Development Department, Eastern Health, Box Hill, Australia)

Advances in Dual Diagnosis

ISSN: 1757-0972

Article publication date: 16 May 2024

7

Abstract

Purpose

This study aims to use the database of consumers referred to the dual diagnosis shared care service to examine those connections. The Eastern Dual Diagnosis Service, based in Melbourne, Australia, has established a database of consumers with co-occurring mental health disorders and problematic substance use. An examination of mental health and substance-use information obtained over a two-year period in the delivery of dual diagnosis shared care to consumers of mental health services is supporting an improved understanding of substance use and the connections to specific mental health diagnoses of schizophrenia, bipolar disorder and schizoaffective disorder.

Design/methodology/approach

This research uses a quantitative approach to review the prevalence of primary substance use and mental health diagnoses for consumers referred to as dual diagnosis shared care. Reviewed are referrals from adult mental health community and rehabilitation teams operating within a mental health and well-being program between January 2019 and December 2020 inclusive.

Findings

Of the 387 clients referred to the specialist dual diagnosis shared care, methamphetamine, alcohol and cannabis are associated with 89.4% of the primary mental health diagnosis (PMHD). The most common PMHDs are schizophrenia, schizoaffective disorder and bipolar disorder. The most common PMHD and substance-use connection was schizophrenia and methamphetamine. Nicotine was reported to be used by 84% of consumers and often occurred in addition to another problematic primary substance.

Originality/value

Improved dual diagnosis data collection from a community-based clinical mental health service is increasing understanding of the mental health and substance-use relationship. This is now providing clarity on routes of investigation into co-occurring mental health and problematic substance-use trends and guiding improved integrated treatments within a contemporary mental health setting.

Keywords

Acknowledgements

The authors wish to acknowledge Sophia Pallis for her dual diagnosis service development leadership and the Eastern Dual Diagnosis Service (EDDS) clinicians for their work and entering the referred consumer details in the database. Eastern Health is a publicly funded health service and funding for this study came from Eastern Health's ongoing operational commitments.

Citation

Foster, G., Taylor, D. and Gough, S. (2024), "Connections between specific mental health diagnoses of schizophrenia, bipolar disorder and schizoaffective disorder and primary substance use", Advances in Dual Diagnosis, Vol. ahead-of-print No. ahead-of-print. https://doi.org/10.1108/ADD-11-2023-0022

Publisher

:

Emerald Publishing Limited

Copyright © 2024, Emerald Publishing Limited

Related articles